Rob Holgate, PhDSenior Director, Protein Engineering and Discovery at Abzena
Profile
Rob has over 20 years experience in Drug Discovery and early stage Development. After obtaining his PhD in Molecular Medicine at UCL, he moved to The University of York as a post-doctoral researcher. He subsequently worked at Cambridge Antibody Technology (now part of AZ) where he was a Senior Scientist within Antibody Engineering then Team Leader of the High Throughput Expression team. Rob joined Antitope (now Abzena) in 2008 as a Research Manager and now leads Abzena’s Discovery and Protein Engineering group overseeing Abzena’s antibody discovery, antibody humanization, protein deimmunisation and bespoke engineering projects.
Agenda Sessions
Addressing the Challenges of Therapeutic Antibody Development through the Application of Design and Developability
8:45amView SessionAddressing the Challenges of Therapeutic Antibody Development through the Application of Design and Developability
On DemandView Session